Improved Glaucoma Medication Access Through Pharmacy Partnership: A Single Institution Experience

References

• Kingman S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ. 2004;82(11):887–888.
   PubMed Web of Science ®Google Scholar
• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224
   PubMed Web of Science ®Google Scholar
• Friedman DS, Wolfs RC, O’Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122(4):532–538.
   PubMedGoogle Scholar
• Vajaranant TS, Wu S, Torres M, Varma R. The changing face of primary open-angle glaucoma in the United States: demographic and geographic changes from 2011 to 2050. Am J Ophthalmol. 2012;154(2):303–314 e303. doi:10.1016/j.ajo.2012.02.024
   PubMed Web of Science ®Google Scholar
• Malvankar-Mehta MS, Feng L, Hutnik CM. North American cost analysis of brand name versus generic drugs for the treatment of glaucoma. Clinicoecon Outcomes Res. 2019;11:789–798. doi:10.2147/CEOR.S156558
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–1279. doi:10.1001/archopht.120.10.1268
   PubMed Web of Science ®Google Scholar
• The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol. 2000;130(4):429–440. doi:10.1016/S0002-9394(00)00538-9
   PubMed Web of Science ®Google Scholar
• Burr J, Azuara-Blanco A, Avenell A, Tuulonen A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev. 2012;9:CD004399. doi:10.1002/14651858.CD004399.pub3
   PubMed Web of Science ®Google Scholar
• Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol. 2016;10:189–206. doi:10.2147/OPTH.S80490
   PubMed Web of Science ®Google Scholar
• Kim CY, Park KH, Ahn J, et al. Treatment patterns and medication adherence of patients with glaucoma in South Korea. Br J Ophthalmol. 2017;101(6):801–807. doi:10.1136/bjophthalmol-2016-308505
   PubMed Web of Science ®Google Scholar
• Chen PP. Blindness in patients with treated open-angle glaucoma. Ophthalmology. 2003;110(4):726–733. doi:10.1016/S0161-6420(02)01974-7
   PubMed Web of Science ®Google Scholar
• Kooner KS, AlBdoor M, Cho BJ, Adams-Huet B. Risk factors for progression to blindness in high tension primary open angle glaucoma: comparison of blind and nonblind subjects. Clin Ophthalmol. 2008;2(4):757–762. doi:10.2147/OPTH.S3139
   PubMedGoogle Scholar
• Paula JS, Furtado JM, Santos AS, Coelho Rde M, Rocha EM, Rodrigues Mde L. Risk factors for blindness in patients with open-angle glaucoma followed-up for at least 15 years. Arq Bras Oftalmol. 2012;75(4):243–246. doi:10.1590/S0004-27492012000400004
   PubMed Web of Science ®Google Scholar
• Sleath B, Robin AL, Covert D, Byrd JE, Tudor G, Svarstad B. Patient-reported behavior and problems in using glaucoma medications. Ophthalmology. 2006;113(3):431–436. doi:10.1016/j.ophtha.2005.10.034
   PubMed Web of Science ®Google Scholar
• Schmier JK, Halpern MT, Jones ML. The economic implications of glaucoma: a literature review. Pharmacoeconomics. 2007;25(4):287–308. doi:10.2165/00019053-200725040-00003
   PubMed Web of Science ®Google Scholar
• Patel SC, Spaeth GL. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 1995;26(3):233–236.
   PubMedGoogle Scholar
• Alexander GC, Casalino LP, Meltzer DO. Patient-physician communication about out-of-pocket costs. JAMA. 2003;290(7):953–958. doi:10.1001/jama.290.7.953
   PubMed Web of Science ®Google Scholar
• Dreer LE, Girkin C, Mansberger SL. Determinants of medication adherence to topical glaucoma therapy. J Glaucoma. 2012;21(4):234–240. doi:10.1097/IJG.0b013e31821dac86
   PubMed Web of Science ®Google Scholar
• Rodin HA, Heaton AH, Wilson AR, Garrett NA, Plocher DW. Plan designs that encourage the use of generic drugs over brand-name drugs: an analysis of a free generic benefit. Am J Manag Care. 2009;15(12):881–888.
   PubMed Web of Science ®Google Scholar
• Egilman AC, Wallach JD, Ross JS, Dhruva SS. Medicare spending and potential savings on brand-name drugs with available generic substitutes excluded by 2 large pharmacy benefit managers, 2012 through 2015. JAMA Intern Med. 2018;178(4):567–569. doi:10.1001/jamainternmed.2017.8016
   PubMed Web of Science ®Google Scholar
• Sleath B, Blalock SJ, Covert D, Skinner AC, Muir KW, Robin AL. Patient race, reported problems in using glaucoma medications, and adherence. ISRN Ophthalmol. 2012;2012:902819. doi:10.5402/2012/902819
   PubMedGoogle Scholar
• Newman-Casey PA, Blachley T, Lee PP, Heisler M, Farris KB, Stein JD. Patterns of glaucoma medication adherence over four years of follow-up. Ophthalmology. 2015;122(10):2010–2021. doi:10.1016/j.ophtha.2015.06.039
   PubMed Web of Science ®Google Scholar
• Slota C, Davis SA, Blalock SJ, et al. Patient-physician communication on medication cost during glaucoma visits. Optom Vis Sci. 2017;94(12):1095–1101. doi:10.1097/OPX.0000000000001139
   PubMed Web of Science ®Google Scholar
• Friedman DS, Hahn SR, Gelb L, et al. Doctor-patient communication, health-related beliefs, and adherence in glaucoma results from the Glaucoma Adherence and Persistency Study. Ophthalmology. 2008;115(8):1320–1327, 1327 e1321–1323. doi:10.1016/j.ophtha.2007.11.023
   Web of Science ®Google Scholar
• Newman-Casey PA, Niziol LM, Lee PP, Musch DC, Resnicow K, Heisler M. The impact of the support, educate, empower personalized glaucoma coaching pilot study on glaucoma medication adherence. Ophthalmol Glaucoma. 2020;3(4):228–237. doi:10.1016/j.ogla.2020.04.013
   PubMedGoogle Scholar
• Gupta D, Ehrlich JR, Newman-Casey PA, Stagg B. Cost-related medication nonadherence in a nationally representative US population with self-reported glaucoma. Ophthalmol Glaucoma. 2021;4(2):126–130. doi:10.1016/j.ogla.2020.08.010
   PubMedGoogle Scholar
• Arora V, Moriates C, Shah N. The challenge of understanding health care costs and charges. AMA J Ethics. 2015;17(11):1046–1052.
   PubMedGoogle Scholar
• Newman-Casey PA, Salman M, Lee PP, Gatwood JD. Cost-utility analysis of glaucoma medication adherence. Ophthalmology. 2020;127(5):589–598. doi:10.1016/j.ophtha.2019.09.041
   PubMed Web of Science ®Google Scholar
• Sloan CE, Millo L, Gutterman S, Ubel PA. Accuracy of physician estimates of out-of-pocket costs for medication filling. JAMA Network Open. 2021;4(11):e2133188. doi:10.1001/jamanetworkopen.2021.33188
   PubMed Web of Science ®Google Scholar